Zonsen Peplib Biotech is a biotech company that completed a Series A+ financing. The company secured 220 million yuan (about $34 million) in the Series A+ round. The article reports the financing amount and round type but does not provide details on the company’s products, roadmap, or operating metrics. No participating investors or use-of-proceeds information were disclosed in the piece. The article likewise does not mention past rounds, founding year, or other financial metrics.

Total raised

$34M

Funding rounds

1

Latest round

Series A

Latest activity

Apr 2021